Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092345 · ClinicalTrials.gov registry record · NA
An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission
A NA study of Suicidal and Self-injurious Behavior and Linkage to Care, sponsored by Rhode Island Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 1
- Study location
NCT07092345: Recruiting NA study of Suicidal and Self-injurious Behavior and Linkage to Care, sponsored by Rhode Island Hospital.
NCT07092345 is a NA study of Suicidal and Self-injurious Behavior and Linkage to Care that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07092345, a NA study of Suicidal and Self-injurious Behavior and Linkage to Care, is actively recruiting participants, sponsored by Rhode Island Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to develop a feasible brief, family-based adaptive intervention, via SMART design, for youth with suicidal and non-suicidal self-injurious behavior (SSIB) to increase community-based mental health (MH) care attendance and reduce SSIB risk post emergency department (ED) admission. The intervention will focus to increase understanding on youth MH literacy, MH communication, and MH engagement. Integrating an adaptive intervention via a SMART design in the ED could address subsequent barriers to youth obtaining appropriate level of community-based MH care and therefore reduce ED readmissions.
Primary Outcome
Recruitment rate (% of ppl who agree to be in the study), Study completion (% of ppl who complete entire study)
Conditions Studied
Interventions
- BEHAVIORAL adaptive intervention
Study Locations (1)
Rhode Island
- Hasbro Children's Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2025-03-17 |
| Est. Completion | 2029-03 |
| Phase | NA |
What NCT07092345 shows while recruiting
NCT07092345 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Suicidal and Self-injurious Behavior appearing as the primary indexed condition, and to 1 intervention - of which adaptive intervention is the first listed.
NCT07092345 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT07092345 about?
NCT07092345 is a clinical study titled "An Adaptive Intervention to Increase Engagement to Community-Based Care After an ED Admission". The goal of this study is to develop a feasible brief, family-based adaptive intervention, via SMART design, for youth with suicidal and non-suicidal self-injurious behavior (SSIB) to increase community-based mental health (MH) care attendance and reduce SSIB risk post emergency department (ED) admi...
What is the current status of trial NCT07092345?
This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2025-03-17. Estimated completion is 2029-03.
What conditions does trial NCT07092345 study?
This clinical trial studies the following conditions: Suicidal and Self-injurious Behavior, Linkage to Care.
What interventions are being tested in trial NCT07092345?
The interventions under investigation include: adaptive intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07092345?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07092345 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicidal and Self-injurious Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07092345's enrollment target sits among peer trials
186 579th of 2000 higher than 1,421 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI